New Directions for CIRM? Closer Links with Industry, Aggressive Search for Innovation, Better Communication
The $3 billion California stem cell agency has done an “extraordinary” job so far, a blue-ribbon review panel said today, and should expand its efforts internationally, create closer ties with the biotech industry and perform triage on its existing portfolio of research grants.
The panel's 19-page report said that the agency now stands at a critical poi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.